The National Institutes of Health will phase out its support of the clinical practice guidelines that advise doctors how to ...

Laekna (2105.HK) announced today that the results of: i) the phase I SAD study of LAE102 (an ActRIIA-selective antibody) for ...

Discover what clinical trials are, why they're vital for new treatments, and how you can participate in life-changing medical ...

Skin grafts genetically engineered from a patient's own cells can heal persistent wounds in people with an extremely painful ...

Most gene therapies being studied for eye diseases are in earlier phases of development, and a third of the gene therapies ...

The traditional approach to trial management relies on a mix of solutions that often become siloed and difficult to integrate ...

Merck’s phase 3 HYPERION study of Winrevair meets primary endpoint in recently diagnosed adults with pulmonary arterial hypertension: Rahway, New Jersey Tuesday, June 24, 2025, ...

A research team was looking to make a new anti-inflammatory medication when they found some incredible side effects ...

A mentorship program for neonatal nurse practitioners in Tennessee receives positive feedback from mentor and mentee ...

Trials enrolling patients with relapsed leukemia, lymphoma and brain cancers, respectively, report early data showing ...

If Island Pharma’s drug keeps delivering, it could fast-track approval. And in a world with millions of dengue cases a year, ...

Psilocybin, the main psychoactive ingredient in magic mushrooms, could alleviate depression for at least five years after just one dose, according to a new study.